22 However, the fact that the magnitude and speed of hemoglobin A1c reduction with treatment were identified as risk factors for progression suggests it could be another example of the well-established early worsening phenomenon first observed in type 1 diabetic patients intensively treated with insulin in the Oslo Study, Kroc Collaborative Study and Diabetes Control and Complications Trial
When switching, it is important to emphasise that treatment burden will not increase and that if gastrointestinal adverse effects occur, they are typically transient
Through this provider, you can access GLP-1s like Zepbound, Wegovy, and Saxenda, in addition to Contrave and Xenical, which are weight loss medications but not GLP-1s
The gradual dose escalation schedule is specifically designed to minimise these symptoms
People working night shifts, eating on the go, sleeping poorly, and other situations often make it easy to gain weight
Weight loss may be slower, and maintaining results requires more attention to protein intake, resistance training, and metabolic support
